Supplementary Figure S8 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma
Year: 2026
Type: supplementary-materials
Abstract: Long-Term Tracking of Eosinophil and Lymphocyte Counts Post-Treatment, related to Figure 4. (A) Total eosinophil and (B) lymphocyte count quantified serially for the duration of study (Day 0 - 120) post-treatment (n = 2 per group). Data are expressed as mean ± SEM.
Authors: Helen D. Clark, Samira Aghlara-Fotovat, Jake Schladenhauffen, Jonathon Debonis, Juan Carlos Amador-Molina, Amanda Nash, Manish Jain, Ryan Newman, Lauren Jansen, Karen Andreas, Kelly Rangel, Travis T. Sims, Bryan Fellman, Claudio Dansky Ullmann, Oladapo Yeku, Amy J. Bregar, Andrew M. Blakely, Cara Mathews, Oleg A. Igoshin, Cara Haymaker, Jose Oberholzer, Peter Rios, Daisy Lopez, Hafsa Nasir, Ira Joshi, Rima Chakrabarti, Omid Veiseh, Amir A. Jazaeri, Shannon N. Westin
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7172245239
Cites:
Cited by:
Related to: